Arabic Arabic English English French French German German
dark

Public Meeting on Patient Focused Drug Development for Pulmonary Arterial Hypertension Part 1

On May 13, 2014, FDA hosted a public meeting on Patient-Focused Drug Development for Pulmonary Arterial Hypertension. FDA was interested in obtaining patient perspectives on the impact of Pulmonary Arterial Hypertension on daily life and patient views on treatment approaches. For more information, visit https://go.usa.gov/x6QqW

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Reducing Social Isolation Is Key to Successful Aging

Next Post

Public Meeting on Patient Focused Drug Development for Pulmonary Arterial Hypertension Part 2

Related Posts
Total
0
Share